Silberhexafluoroantimonat(1-)

Silver hexafluoroantimonate

HCID 16687962

Grundinformationen

CAS
26042-64-8
Standard-SMILES
[Ag+].[F][Sb-]([F])([F])([F])([F])[F]
InChIKey
GSXFODUDOAXUBF-UHFFFAOYSA-H
Summenformel
AgF6Sb
Durchschnittliche Molmasse
343,619 g/mol
Monoisotopische Masse
341,79932

Namen und Bezeichner

Bevorzugter Name
Silver hexafluoroantimonate
IUPAC
silver hexafluoroantimony(1-)
Lokaler Name
Silberhexafluoroantimonat(1-)
Englischer Name
Silver hexafluoroantimonate
Summenformel
AgF6Sb
Molmasse
343.62

Namen und Synonyme

Silver hexafluoroantimonate26042-64-8EINECS 247-429-1Antimonate(1-), hexafluoro-, silver(1+), (OC-6-11)-RefChem:183038DTXCID901473801DTXSID201015535Silver hexafluoroantimonate(V)Silverhexafluoroantimonatesilver;hexafluoroantimony(1-)MFCD00003401AgSbF6
Weitere Namen anzeigen
SILVER(I) HEXAFLUOROANTIMONATESilverhexafluoroantimonate(V),98%ver hexafLuoroantimonate(V)SILVER HEXAFLUOROSILICATEsilver,hexafluoroantimony(1-)Silverhexafluoroantimonate98%Silver hexafluorosilicate ,99%
silver hexafluorostibate(V)silver (I)hexafluoroantimonateSCHEMBL21580272Silver hexafluoroantimonate(V), 98%AKOS015904205SY010064DB-231767NS00084211

Datenbank-Bezeichner

CAS
26042-64-8
PubChem CID
16687962

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
0 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
7
Frei drehbare Bindungen
0
Schwere Atome
8

Physikochemische Eigenschaften

storage temp.
Keep in dark place,Inert atmosphere,Room temperature
Löslichkeit
sol (and forms 1:2 complexes with) benzene, toluene, xylene; sol nitromethane, liq SO2; insol HF, petroleum ether.
Aggregatzustand
Powder/Lump
Farbe
White to pale yellow
Wasserlöslichkeit
Soluble in water.
Stabilität
hygroscopic

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 5 Einträge

Danger

H302 (96%): Harmful if swallowed [Warning Acute toxicity, oral];H314 (22%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation];H332 (96%): Harmful if inhaled [Warning Acute toxicity, inhalation];H411 (92%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]

P260, P261, P264, P270, P271, P273, P280, P301+P317, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P321, P330, P363, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 50 reports by companies from 9 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

Gefahrenhinweise

Hazard Classes and CategoriesAcute Tox. 4 (96%);Skin Corr. 1B (22%);Acute Tox. 4 (96%);Aquatic Chronic 2 (92%)

Toxikologische Informationen

Treatment · 1 Eintrag

Following oral exposure to antimony, administer charcoal as a slurry (240 mL water/30 g charcoal). Following inhalation exposure, move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with inhaled beta2 agonist and oral or parenteral corticosteroids. In case of eye exposure, irrigate exposed eyes with copious amounts of room temperature water for at least 15 minutes. Following dermal exposure, Remove contaminated clothing and wash exposed area thoroughly with soap and water. A physician may need to examine the area if irritation or pain persists. (T36)

Health Effects · 1 Eintrag

Dermal exposure to antimony can cause antimony spots (papules and pustules around sweat and sebaceous glands). Antimony poisoning can also lead to pneumoconiosis. Alterations in pulmonary function and other effects including chronic bronchitis, chronic emphysema, inactive tuberculosis, pleural adhesions, and irritation can result from inhalation of antimony. Increased blood pressure can also result from antimony poisoning. Myocardial depression, vasodilation and fluid loss may cause shock with hypotension, electrolyte disturbances and acute renal failure. Cerebral oedema, coma, convulsions, and death are possible. Exposure to high levels of silver for a long period of time may result in a condition called arygria, a blue-gray discoloration of the skin and other body tissues. Argyria is a permanent effect but does not appear to be harmful to health. While silver itself is not toxic, most silver salts are, and may damage the liver, kidney, and central nervous system, as well as be carcinogenic. (L808, L809, L810, L741)

Exposure RoutesInhalation (L741) ; oral (L741) ; dermal (L741)
Toxicity Summary · 1 Eintrag

The inhalation data suggests that the myocardium is a target of antimony toxicity. It is possible that antimony affects circulating glucose by interfering with enzymes of the glycogenolysis and gluconeogenesis pathways. The mechanism of action of antimony remains unclear. However, some studies suggest that antimony combines with sulfhydryl groups including those in several enzymes important for tissue respiration. The antidotal action of BAL depends on its ability to prevent or break the union between antimony and vital enzymes. Moreover, the The cause of death is believed to be essentially the same as that in acute arsenic poisoning. Metallic silver is oxidized and may deposit in the tissues, causing arygria. The silver ion is known to inhibit glutathione peroxidase and NA+,K+-ATPase activity, disrupting selenium-catalyzed sulfhydryl oxidation-reduction reactions and intracellular ion concentrations, respectively. Silver nanoparticles are believed to disrupt the mitochondrial respiratory chain, causing oxidative stress, reduced ATP synthesis, and DNA damage. (L808, A243, A244, A245, A246, T18, L741, A238)

Signs and Symptoms · 1 Eintrag

Abdominal pain, vomiting, diarrhea can result from inhalation of antimony. Dyspnea, headache, vomiting,cough, conjunctivitis, and bloody purulent discharge from nose can result from inhalation exposure. Skin or eye contact can cause pain and redness of the exposed surface. Exposure to high levels of silver for a long period of time may result in a condition called arygria, a blue-gray discoloration of the skin and other body tissues. Argyria is a permanent effect but does not appear to be harmful to health. Exposure to high levels of silver in the air has resulted in breathing problems, lung and throat irritation, and stomach pains. Skin contact with silver can cause mild allergic reactions such as rash, swelling, and inflammation in some people. (L808, T64, L741)

Carcinogen ClassificationNo indication of carcinogenicity (not listed by IARC). (L135)

Sicherheitsdaten

F
3-8-10
wgk
2
tsca
TSCA listed
ridadr
UN 3260 8/PG 2
hs_code
28432900
risk_code
20/22-51/53

Chemie und Industrie

Pharmakologische Informationen

Metabolism/Metabolites · 1 Eintrag

Antimony is widely distributed throughout the body. The hair and skin contain the highest levels of antimony. The adrenal glands, lung, large intestine, trachea, cerebellum, and kidneys also contain relatively high levels of antimony. Blood is the main vehicle for the transport of absorbed antimony to various tissue compartments of the body. Antimony is a metal and, therefore, does not undergo catabolism. Antimony can covalently interact with sulfhydryl groups and phosphate, as well as numerous reversible binding interactions with endogenous ligands (e.g., proteins). It is not known if these interactions are toxicologically significant. Antimony is excreted via the urine and feces. Some of the fecal antimony may represent unabsorbed antimony that is cleared from the lung via mucociliary action into the esophagus to the gastrointestinal tract. Silver and its compounds can be absorbed via inhalation, while silver compounds can also be absorbed orally and dermally. It distributes throughout the body in the blood, particularily to the liver. Insoluble silver salts are transformed into soluble silver sulfide albuminates, bind to amino or carboxyl groups in RNA, DNA, and proteins, or are reduced to metallic silver by ascorbic acid or catecholamines. Metallic silver is oxidized and may deposit in the tissues, causing arygria. Silver is eliminated primarily in the faeces. (L808, L741)

Verwendung und Herstellung

UsesBreathing air, drinking water, and eating foods that contain antimony. Exposure can also occur through dermal or skin contact (L741).
General Manufacturing InformationAntimonate(1-), hexafluoro-, silver(1+) (1:1), (OC-6-11)-: ACTIVE

Anwendungen

VerwendenSilver Hexafluoroantimonate(V) is used as a catalyst in the synthesis of isocoumarins through benzothiadiazine-fused.

Darstellung · 1 Eintrag

synthetischeSilver hexafluoroantimonate has been made from SbF3 (or Sb2O3), AgCl, and Bromine Trifluoride, but is more readily prepared by reacting Antimony(V) Fluoride and Silver(I) Fluoride in anhydrous HF at -78 to 0 °C, washing with pet ether, and drying in vacuo.

Anbieter97 Anbieter

梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
湖北永阔科技有限公司027-59223108 15972152991 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
湖南韵邦生物科技股份有限公司85561037 15386497078 · [email protected]
湖北万得化工有限公司15377098680 15377098680 · [email protected]

Zugehörige Reaktionen

103

Notizen zur Verbindung

Wird geladen…